Regulation of intestinal homeostasis and tumorigenesis by the transcriptional coregulator RIP140

Vincent Cavaillès1, Marion Lapierre1

  • 1IRCM; Institut de Recherche en Cancérologie de Montpellier; INSERM U896; Université Montpellier1 ; Montpellier, France.

Insights

Researchers found that RIP140 activates the adenomatous polyposis coli (APC) gene, inhibiting colon cancer growth by reducing Wnt signaling and beta-catenin activation. This discovery offers a new target for colon cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Colon cancer often arises from mutations activating the Wnt signaling pathway.
  • The tumor suppressor gene adenomatous polyposis coli (APC) is a key target in Wnt pathway dysregulation.

Purpose of the Study:

  • To identify novel regulators of APC gene transcription.
  • To investigate the role of RIP140 in colon cancer cell growth and Wnt signaling.

Main Methods:

  • Gene expression analysis to identify RIP140 as an APC inducer.
  • Cell-based assays to assess the impact of RIP140 on colon cancer cell proliferation.
  • Western blotting to measure beta-catenin activation levels.

Main Results:

  • RIP140 was identified as a novel inducer of APC gene transcription.
  • RIP140 significantly inhibited colon cancer cell growth.
  • RIP140 reduced beta-catenin activation, thereby impeding the Wnt signaling pathway.

Conclusions:

  • RIP140 acts as a tumor suppressor in colon cancer by upregulating APC.
  • Targeting RIP140 or its pathway presents a potential therapeutic strategy for colon cancer.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K